X4 Pharmaceuticals, Inc.XFORNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-131.23M
↓ 124% below average
Average (9y)
$-58.65M
Historical baseline
Range
High:$-10.99M
Low:$-131.23M
CAGR
+31.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-131.23M | -35.9% |
| 2023 | $-96.57M | -25.1% |
| 2022 | $-77.20M | -7.9% |
| 2021 | $-71.52M | -18.8% |
| 2020 | $-60.18M | -24.8% |
| 2019 | $-48.23M | -17.8% |
| 2018 | $-40.94M | -46.7% |
| 2017 | $-27.91M | -28.6% |
| 2016 | $-21.71M | -97.6% |
| 2015 | $-10.99M | - |